Posterior Uveitis
Links shared publicly online about this topic
Can Retisert Be Used to Treat Uveitis?
eyedocnews.com — “Jancevski, MD and colleagues report on the safety of Retisert for patients with intermediate or posterior uveitis. Their study involved 64 eyes of 51” View full resource at eyedocnews.com
Most Recently Shared on May 12, 2010 at 5:45 pm By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: Retisert Indicated for Uveitis?: By Dr. Randall WongJancevski, MD and colleagues report on the safety of ... http://bit.ly/9Sg8VD
Iritis and Uveitis: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Uveitis is defined as inflammation of one or all parts of the uveal tract. Components of the uveal tract include the iris, the ciliary body, and the choroid. Uveitis may involve all areas of the uveal ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 28, 2010 at 4:53 am By:
Inflammation in the uveal tract (uveitis) may refer to a number of conditions, including iritis. Learn more about it. http://bit.ly/bC2ZHi
Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
agn.client.shareholder.com — “Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye” View full resource at agn.client.shareholder.com
Most Recently Shared on September 24, 2010 at 8:37 pm By:
eyeonfda Pharma and Health Lawyer
Allergan Gets FDA OK 4 OZURDEX(R) - Trtmnt Option 4 Non-Infectious Uveitis Affecting Posterior Segment of the Eye http://ow.ly/2JA4J
Ozurdex approved for non-infectious uveitis - ONA
oncologynurseadvisor.com — “The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 28, 2010 at 6:07 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Ozurdex approved for non-infectious uveitis http://goo.gl/fb/ECaKn
Ozurdex approved for non-infectious uveitis - MPR
empr.com — “The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.” View full resource at empr.com
Most Recently Shared on September 28, 2010 at 5:20 pm By:
MPR News: Ozurdex approved for non-infectious uveitis: The FDA has approved Ozurdex (dexamethasone intravitreal im... http://bit.ly/9QhxHZ
FDA approves OZURDEX implant for uveitis treatment
news-medical.net — “Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.” View full resource at news-medical.net
Most Recently Shared on September 27, 2010 at 8:13 am By:
Obesity News: FDA approves OZURDEX implant for uveitis treatment: Allergan, Inc. today announced that the United S... http://bit.ly/9kS2e6
Medical News: Steroid Reduces Noninfectious Uveitis - in Ophthalmology, Ophthalmology from MedPage Today
medpagetoday.com — “Patients with noninfectious or posterior uveitis had significant improvement with a single intravitreal dexamethasone implant, results of a sham-control trial showed.” View full resource at medpagetoday.com
Most Recently Shared on January 11, 2011 at 4:20 pm By:
Steroid Reduces Noninfectious Uveitis (CME/CE) http://bit.ly/hXDuoC
Orphan Drug Status for Sirolimus for Non-Infectious Uveitis - MPR
empr.com — “Santen Inc. announced that the FDA has granted orphan drug designation for sirolimus (DE-109) for the treatment of chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, non-infectious panuveitis, and non-infectious uveitis affecting the posterior segment of the eye.” View full resource at empr.com
Most Recently Shared on November 11, 2011 at 2:32 pm By:
Orphan Drug Status for Sirolimus for Non-Infectious #Uveitis http://t.co/vLl947Hz
Steroid Reduces Noninfectious Uveitis (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Patients with noninfectious or posterior uveitis had significant improvement with a single intravitreal dexamethasone implant, results of a sham-control trial showed.” View full resource at qualitypointtech.net
Most Recently Shared on January 11, 2011 at 4:46 pm By:
Steroid Reduces Noninfectious Uveitis (CME/CE): (MedPage Today) -- Patients with noninfectious or posterior uveiti... http://bit.ly/i2KCm2
FDA Advisory Committee To Review Lux Biosciences' Uveitis Candidate Luveniq™
medicalnewstoday.com — “Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application” View full resource at medicalnewstoday.com
Most Recently Shared on May 13, 2010 at 3:12 am By:
FDA Advisory Committee To Review Lux Biosciences' Uveitis Candidate Luveniq™ http://mnt.to/3Cx6 #eyehealth
Lux Biosciences Files For LUVENIQ™ Approval In US And Europe For Noninfectious Uveitis
medicalnewstoday.com — “Lux Biosciences, Inc. today announced its submission of simultaneous regulatory filings to both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking marketing ap” View full resource at medicalnewstoday.com
Most Recently Shared on February 6, 2010 at 9:07 am By:
Lux Biosciences Files For LUVENIQâ„¢ Approval In US And Europe For Noninfectious Uveitis Lux Biosciences, Inc. today .. http://bit.ly/cOKayN
Dexamethasone can be used to treat non-infectious uveitis - Ophthalmology Times Europe
oteurope.com — “Ozurdex (dexamethasone) can now be used for the treatment of inflammation of the posterior segment of the eye characterized as non-infectious uveitis” View full resource at oteurope.com
Most Recently Shared on April 27, 2011 at 12:33 pm By:
Ophthalmology Times Health Magazine and Ophthalmology
News Update: Dexamethasone can be used to treat non-infectious uveitis http://ow.ly/1cmI32
Behcet Disease: eMedicine Dermatology
emedicine.medscape.com — “Overview: Behcet disease (BD) was named in 1937 after the Turkish dermatologist Hulusi Behcet, who first described the triple-symptom complex of recurrent oral aphthous ulcers, genital ulcers, and uveitis.1Behcet disease is a complex, multisystemic disease that ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 22, 2010 at 4:07 pm By:
Susan Scroggins Health Advocate and Active Health Library
Behçet disease is a rare disorder that causes chronic inflammation in the blood vessels of the body. http://bit.ly/aDLSde
FDA Dermatology and Ophthalmology Drugs Advisory Committee to review Lux Biosciences' Luveniq NDA
news-medical.net — “Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq" (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.” View full resource at news-medical.net
Most Recently Shared on May 12, 2010 at 7:10 am By:
FDA Dermatology and Ophthalmology Drugs Advisory Committee to review Lux Biosciences’ Luveniq NDA: Lux Biosciences... http://bit.ly/bFVc4x
Isotechnika's partner Lux to appeal EMA CHMP decision against Luveniq
news-medical.net — “Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc. will appeal the European Medicines Agency's (EMA) decision not to approve Luveniq™ (voclosporin) as a treatment for noninfectious uveitis involving the intermediate or posterior segments of the eye.” View full resource at news-medical.net
Most Recently Shared on June 24, 2011 at 5:19 pm By:
Isotechnika's partner Lux to appeal EMA CHMP decision against Luveniq: Isotechnika Pharma Inc. today announced t... http://bit.ly/jEZHbZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Dr. Ari Weitzner
Brooklyn, NY Ophthalmologist; Editor of EyeDocNews; Founder of Share Medical Space
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
